Profile
| Metric | Value |
|---|---|
| Full Name | Alvotech |
| Ticker | NASDAQ: ALVO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Luxembourg |
| IPO | |
| Indexes | Not included |
| Website | alvotech.com |
| Employees | 1,012 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $5.17 | |
| Price, 1D Change | +2.58% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | 22.45 | |
| Beta | 0.86 | |
| Revenue | $490M | |
| Revenue, 1Y Change | +435.56% | |
| EPS | -$0.87 | |
| EPS, 1Y Change | +64.35% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.87 | |
| EPS Estimate | -$0.08 | |
| EPS Est. Change | +91.08% | |
| Revenue | $489.68M | |
| Revenue Estimate | $582.88M | |
| Revenue Est. Change | +19.03% | |
| Current Price | $5.17 | |
| Price Target | - | $10.00 |
| Price Tgt. Change | - | +93.42% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.12 | -$2.43 | -116.77% | |
| -$0.42 | -$0.87 | -107.98% | |
| -$0.08 | N/A | +91.08% | |
| $0.34 | N/A | +139.68% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $112.47M | $91.43M | -18.70% | |
| $454.43M | $489.68M | +7.76% | |
| $582.88M | N/A | +19.03% | |
| $842.22M | N/A | +71.99% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -60.59% | |
| Price, 3Y | -56.66% | |
| Market Cap, 1Y | -59.32% | |
| Market Cap, 3Y | -45.69% | |
| Revenue, 1Y | +435.56% | |
| Revenue, 3Y | +100.00% | |
| EPS, 1Y | +64.35% | |
| EPS, 3Y | -777.15% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $5.17 | |
| SMA 200 | $7.82 | |
| SMA 200 vs Price | +51.22% | |
| SMA 50 | $5.11 | |
| SMA 50 vs Price | -1.08% | |
| Beta | 0.86 | |
| ATR | $0.27 | |
| 14-Day RSI | 53.58 | |
| 10-Day Volatility | 41.39% | |
| 1-Year Volatility | 66.27% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $489.68M | |
| EPS | -$0.87 | |
| Gross Profit | $291.76M | |
| Gross Margin | 59.58% | |
| Operating Profit | $69.64M | |
| Operating Margin | 14.22% | |
| Net Income | -$231.86M | |
| Net Margin | -47.35% | |
| EBITDA | -$32.28M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -2.88 | |
| Current Ratio | 2.35 | |
| Quick Ratio | 1.69 | |
| Interest Coverage | -0.41 | |
| F-Score | 4 | |
| Altman Z-Score | -1.72 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 22.45 | |
| PS Ratio | 2.94 | |
| PB Ratio | -9.11 | |
| EV/EBITDA | 53.02 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$412.77M | |
| Cash & Equivalents | $51.43M | |
| Total Assets | $1.22B | |
| Current Assets | $455.02M | |
| Total Liabilities | $1.63B | |
| Current Liabilities | $193.40M | |
| Total Debt | $1.19B | |
| Short Term Debt | $42.22M | |
| Accounts Payable | $67.13M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $420.04M | |
| Operating Expenses | $234.73M | |
| Cost Of Goods Sold | $197.93M | |
| SG&A | $61.45M | |
| D&A | $31.30M | |
| Interest Expense | $153.99M | |
| Income Tax | $14.30M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$236.84M | |
| CFI | -$18.87M | |
| CFF | $297.31M | |
| Capex | $57.00M | |
| Free Cash Flow | -$293.84M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| UBS | → | |
| Deutsche Bank | → | |
| Morgan Stanley | → | |
| Deutsche Bank | → | |
| UBS | → | |
| UBS | ||
| Barclays | → | |
| Barclays | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with ALVO
FAQ
What is the ticker symbol for Alvotech?
The ticker symbol for Alvotech is NASDAQ:ALVO
Does Alvotech pay dividends?
No, Alvotech does not pay dividends
What sector is Alvotech in?
Alvotech is in the Healthcare sector
What industry is Alvotech in?
Alvotech is in the Specialty & Generic Drug Manufacturers industry
What country is Alvotech based in?
Alvotech is headquartered in Luxembourg
When did Alvotech go public?
Alvotech initial public offering (IPO) was on June 16, 2022
Is Alvotech in the S&P 500?
No, Alvotech is not included in the S&P 500 index
Is Alvotech in the NASDAQ 100?
No, Alvotech is not included in the NASDAQ 100 index
Is Alvotech in the Dow Jones?
No, Alvotech is not included in the Dow Jones index
When was Alvotech last earnings report?
Alvotech's most recent earnings report was on November 12, 2025
When does Alvotech report earnings?
The next expected earnings date for Alvotech is March 18, 2026
Data Sources & References
- ALVO Official Website www.alvotech.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1898416/000162828025015052/0001628280-25-015052-index.htm
- ALVO Profile on Yahoo Finance finance.yahoo.com/quote/ALVO
- ALVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alvo